Skip to content
Medical Health Aged Care

The Babyface Study: the impact of only seeing masked faces during COVID on facial perception in NICU babies

Monash University 2 mins read

While newborns are known to show a preference for faces, it is thought that continued exposure to faces, particularly those of parents, after birth are critical for developing the brain networks that will help the child navigate social situations later in life. 

During the COVID-19 pandemic, mandatory mask-wearing in most neonatal intensive care units (NICUs) brought an additional challenge on face exposure and perception in NICU patients, who are often premature. The Babyface Study aimed to assess the impact of face masks on face perception in these vulnerable babies.

Led by Dr Flora Wong, from Monash University and Monash Health, and Dr Robin Laycock from RMIT and published in the journal, Scientific Reports, the study assessed 24 preterm (23-30 weeks gestation at birth) and 24 term-born infants at six months of post-term age, using functional near-infrared spectroscopy. This non-invasive brain imaging technique measures brain activity via the detection of changes in blood oxygenation. 

The infants viewed alternating five second trials of images of full or masked happy faces, interspersed with 15 second baseline trials. 

The control group – babies born at full-term – showed higher brain responses and activations than preterm infants for full faces. 

According to Dr Wong, the study’s findings “reveal lower brain activation in preterm compared to term infants in the inferior-frontal region of the brain, which is important for face and emotion processing,” she said. 

Preterm infants are known to have a higher risk of socio-cognitive dysfunction which disrupts their understanding and response to social information, leading to reduced social engagement, attention and behaviour like cooperation and sharing.

Preterm children also have increased incidence of neurodevelopmental disorders such as autism spectrum disorder and attention-deficit/hyperactivity disorder, both of which involve socio-cognitive dysfunction and are often characterised by atypical responses to faces, such as impaired eye-contact and difficulty in reading facial expressions.

“We already know that while full term infants within 48 hours after birth demonstrate preferential looking at natural compared to distorted face images, preterm infants do not differentiate between these stimuli,” Dr Laycock said. 

“Now, our study has also revealed that the term-born infants showed higher brain activations for full than masked faces, but preterm infants' brain responses do not differ between these faces.”

The study will further assess the participants in the study at two years of age. “The result will reveal whether the brain response to face perception at early infancy is related to socio-cognitive deficits in preterm infants, and its potential as an early marker of neurodevelopmental outcomes,” Dr Wong said.

“Current early follow-up after preterm birth focuses on motor development, to screen for motor disorders such as cerebral palsy at 3-4 months of post-term age. Early socio-cognitive assessment remains limited and may be overlooked until a later age.”

 

Read full paper in the journal, Scientific Reports:  Face perception and impact of face masks at 6 months post-term age in preterm and term infants (The BabyFace Study).

DOI: https://doi.org/10.1038/s41598-026-48027-y


Contact details:

For media enquiries please contact:

 

Monash University

Tania Ewing Media and Communications Contractor
E:
[email protected]

T: +61 (0) 408 378 422

 

For more Monash media stories, visit our news and events site 


For general media enquiries please contact:
Monash Media
E: 
[email protected]
T: +61 (0) 3 9903 4840

More from this category

  • Medical Health Aged Care
  • 07/06/2026
  • 05:00
Dementia Australia

Join us today for the Gold Coast Memory Walk & Jog

What: Dementia Australia’s Gold Coast Memory Walk & Jog   When: Sunday 7 June from 7:30am   Who: More than 880 locals participating on the day. People who have been impacted by dementia, their family, friends and carers. Special guest MC Takaya Honda. Where: Pratten Park   Dementia Australia spokespeople and local residents are available for interview. Photos and video of previous Memory Walk & Jog events for publication are available for use. For more information visit: www.memorywalk.com.au Dementia Australia is the source of trusted information, education and services for the estimated more than 446,500 Australians living with dementia, and…

  • Contains:
  • Medical Health Aged Care
  • 06/06/2026
  • 05:00
Dementia Australia

Join us today for the Redcliffe Memory Walk & Jog

What: Dementia Australia’s Redcliffe Memory Walk & Jog   When: Saturday 6 June from 7:30am   Who: More than 880 locals participating on the day. People who have been impacted by dementia, their family, friends and carers. Special guests MC’s Pat Welsh and Wally Lewis. Where: Scarborough Beach Park   Dementia Australia spokespeople and local residents are available for interview. Photos and video of previous Memory Walk & Jog events for publication are available for use. For more information visit: www.memorywalk.com.au Dementia Australia is the source of trusted information, education and services for the estimated more than 446,500 Australians living…

  • Contains:
  • Medical Health Aged Care
  • 06/06/2026
  • 02:02
EnGeneIC

EnGeneIC Honored with 2026 Breakthrough in Glioblastoma Biotech Award at Northwell Foundation Lenox Hill Neurosurgery Brain Cancer Gala in New York

SYDNEY and NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- EnGeneIC Limited today announced it has been recognized with the Breakthrough in glioblastoma Biotech Award 2026 at the Northwell Foundation, Lenox Hill Neurosurgery Brain Tumor Center Gala event in New York City. The award was presented to Joint-CEO’s and co-inventors Dr. Himanshu Brahmbhatt and Dr. Jennifer MacDiarmid on June 4, 2026.The award recognizes EnGeneIC’s advancement of novel cyto-immunotherapy using its proprietary EnGeneIC Dream Vector (EDV™) nanocell platform. The technology is designed to bypass the blood brain barrier, selectively target tumors, deliver potent therapeutic payloads inside cancer cells, and activate both…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.